Antiretroviral therapy in resource-poor countries: Illusions and realities

被引:6
作者
Desvarieux, M [1 ]
Landman, R
Liautaud, B
Girard, PM
机构
[1] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA
[2] Univ Paris, CHU Bichat Claude Bernard, Serv Malad Infect, Paris, France
[3] IMEA, Paris, France
[4] Grp Haitien Etudes Sarcome Kapolsi & Infect Oppor, Port Au Prince, Haiti
[5] Univ Paris, Ctr Hosp Univ St Antoine, Serv Malad Infect & Trop, Paris, France
[6] Inst Med & Epidemiol Appliquee, Paris, France
关键词
D O I
10.2105/AJPH.2003.034249
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The prospects for antiretroviral therapy in resource-poor settings have changed recently and considerably with the availability of generic drugs, the drastic price reduction of brand-name drugs, and the simplification of treatment. However, such cost reductions, although allowing the implementation of large-scale donor programs, have yet to render treatment accessible and possible in the general population. Successfully providing HIV treatment in high-prevalence/ high-caseload countries may require that we redefine the problem as a public health mass therapy program rather than a multiplication of clinical situations. The public health goal cannot simply be the reduction of morbidity and mortality for those treated but must be the reduction in morbidity and mortality for the many, that is, at a population level.
引用
收藏
页码:1117 / 1122
页数:6
相关论文
共 35 条
[1]  
*AG NAC RECH SID I, US ANT DRUGS MAN HIV
[2]  
[Anonymous], 2001, ARSENIC ARSENIC COMP, P1
[3]   An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries [J].
Balakrishnan, P ;
Dunne, M ;
Kumarasamy, N ;
Crowe, S ;
Subbulakshmi, G ;
Ganesh, AK ;
Cecelia, AJ ;
Roth, P ;
Mayer, KH ;
Thyagarajan, SP ;
Solomon, S .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (05) :1006-1010
[5]   Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].
Coetzee, D ;
Hildebrand, K ;
Boulle, A ;
Maartens, G ;
Louis, F ;
Labatala, V ;
Reuter, H ;
Ntwana, N ;
Goemaere, E .
AIDS, 2004, 18 (06) :887-895
[6]   Addressing the educational void during the antiretroviral therapy rollout [J].
Cohen, J ;
Kimaiyo, S ;
Nyandiko, W ;
Siika, A ;
Sidle, J ;
Wools-Kaloustian, K ;
Mamlin, J ;
Carter, EL .
AIDS, 2004, 18 (15) :2105-2106
[7]   Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century [J].
De Cock, KM ;
Mbori-Ngacha, D ;
Marum, E .
LANCET, 2002, 360 (9326) :67-72
[8]   Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings:: the ANRS 12-26 study [J].
Diagbouga, S ;
Chazallon, C ;
Kazatchkine, MD ;
de Perre, PV ;
Inwoley, A ;
M'Boup, S ;
David, MP ;
Ténin, AT ;
Soudré, R ;
Aboulker, JP ;
Weiss, L .
AIDS, 2003, 17 (15) :2201-2208
[9]   Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries [J].
Didier, JM ;
Kazatchkine, MD ;
Demouchy, C ;
Moat, C ;
Diagbouga, S ;
Sepulveda, C ;
Di Lonardo, AM ;
Weiss, L .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02) :193-195
[10]  
*DOTS PLUS GREEN L, WHO